Smitirupa Mishra: Standardizing RBC Morphology Reporting – Why ICSH Guidelines Matter?
Smitirupa Mishra, Consultant Pathologist at Sparsh Hospitals and Lab Head at Pathkind Labs, shared a post on LinkedIn:
“Standardizing RBC Morphology Reporting: Why ICSH Guidelines Matter
Red blood cell morphology remains one of the most valuable components of peripheral smear examination.
However, it is also one of the areas where significant inter-observer variability exists.
Terms such as ‘few’, ‘occasional’, ‘mild’, or ‘moderate’ may mean different things to different observers, leading to confusion among clinicians and inconsistency across laboratories.
This is where the International Council for Standardization in Haematology (ICSH) guidelines play a crucial role.
The ICSH recommendations provide a standardized framework for reporting RBC morphological abnormalities, including:
- Anisocytosis
- Microcytosis and Macrocytosis
- Hypochromia
- Target cells
- Elliptocytes
- Spherocytes
- Schistocytes
- RBC inclusions and other poikilocytes
By defining percentage-based grading criteria, the guidelines help:
- Reduce subjectivity in reporting
- Improve inter-laboratory consistency
- Enhance communication with clinicians
- Facilitate better patient management and follow-up
- Strengthen quality assurance practices in hematology laboratories
One particularly important aspect is the reporting of schistocytes, where even small percentages can have significant clinical implications and may point toward life-threatening thrombotic microangiopathies.
As laboratory professionals, adopting standardized reporting systems is not merely about compliance—it is about improving diagnostic accuracy and ensuring that every morphology report conveys clear, reproducible, and clinically meaningful information.
The next time you report an RBC morphology, ask yourself:
Are we describing what we see, or are we reporting it in a standardized manner that others can interpret consistently?
Standardization transforms morphology from an art into a reproducible science.”

Stay updated with Hemostasis Today.
-
Aug 31, 2026, 05:35Does LDL Cholesterol Influence VTE Risk? – Ordo Fraterna Fibonacci
-
Aug 31, 2026, 05:19Tania Ahuja: Apixaban in Abdominal Transplant Patients
-
Aug 31, 2026, 04:28Reza Hafidz IrawanÖ‰ Automated Antibody Titration With Erytra Eflexis
-
Aug 31, 2026, 04:17Safa Chenganath: Stenosis vs Thrombosis – Hemodialysis Vascular Access
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session